Press "Enter" to skip to content

Lymphoma Therapy Candidate TRQ-1501 Gets FDA’s Fast Track Status – Immuno-Oncology News

admin 0

Lymphoma Therapy Candidate TRQ-1501 Gets FDA’s Fast Track Status  Immuno-Oncology News

TRQ-1501 has received Fast Track designation from the FDA for the treatment of certain hard-to-treat solid tumors and lymphomas.

“lymphoma cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *